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Abstract
Background: The global burden of chronic liver disease is rising. Besides environmental, behavioral, viral and
metabolic factors, genetic polymorphisms in patatin-like phospholipase-3 (PNPLA3) and vitamin D receptor (VDR)
genes have been related to the development of chronic liver disease and progression towards liver cancer.
Although their prevalence differs remarkably among ethnic groups, the frequency of these polymorphisms in South
American populations -whose genetic background is highly admixed- has been poorly studied. Hence, the aim of
this study was to characterize polymorphisms related to chronic liver disease and their association with the genetic
ancestry of South American populations.
Results: DNA samples from 258 healthy unrelated male volunteers were analyzed. The frequencies of G and C alleles of
rs738409 polymorphism (PNPLA3 gene) were 74 % and 26 %, respectively; whereas the bAt (CCA) haplotype (VDR gene)
was observed in 32.5 % of the samples. The GG genotype of PNPLA3 rs738409 and the bAt (CCA) haplotype
-associated with an increased risk of chronic liver disease and progression towards liver cancer- were significantly
more frequent among samples exhibiting maternal and paternal Native American haplogroups (63.7 % and
64.6 %), intermediate among admixed samples (45.1 % and 44.9 %; p = 0.03) and the lowest for Non-native
American ancestry (30.1 % and 29.6 %; p = 0.001 and p = 0.0008).
Conclusions: These results suggest that individuals with Native American ancestry might have a high risk of
chronic liver disorders and cancer. Furthermore, these data not only support the molecular evaluation of ancestry
in multi-ethnic population studies, but also suggest that the characterization of these variants in South American
populations may be useful for establishing public health policies aimed at high risk ethnic communities.
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Background
The global health and economic burden of chronic liver
disease is substantial and on the rise, due in part to the
growing incidence of hepatic steatosis and cirrhosis [1, 2].
The increase in cirrhosis, along with a surge in the preva-
lence of its risk factors such as alcohol abuse and infection
with hepatitis B virus (HBV) and/or hepatitis C virus
(HCV), has resulted in a growing incidence of primary liver
cancer [3]. The major histological subtype of primary liver
malignancies, hepatocellular carcinoma (HCC), represents
the end stage of the natural history of chronic liver disease
and has become the third leading cause of cancer-related
mortality worldwide and the major indication for liver
transplant in Europe and USA [4].
Hepatic steatosis is the most common pathological
finding in liver biopsies around the world [5]. Although
its association with liver inflammation is an evidence
suggestive of alcohol-induced liver injury, it has also
been described in individuals with no significant history
of alcohol ingestion [6, 7]. The term non-alcoholic fatty
liver disease (NAFLD) has been adopted to cover the
full spectrum of metabolic fatty liver disorders, as it
ranges from simple steatosis to non-alcoholic steatohe-
patitis (NASH) and fibrosis with severe disruption of
the normal architecture and function of the liver leading
to cirrhosis [6, 7]. Increasing rates of NAFLD and
NASH -the most common forms of chronic liver disease
in Western countries- have been reported as the world-
wide prevalence of obesity continues to rise [5–7]. In
turn, obesity, NAFLD and NASH are increasingly rec-
ognized triggers involved in the development of both
cirrhosis and HCC [8].
There is consistent evidence that the burden of
chronic liver disease is greater among certain ethnic
groups, particularly in areas characterized by high rates
of chronic infection with hepatitis viruses [9]. Moreover,
racial disparities in the prevalence and clinical presentation
of chronic liver disorders have frequently been reported. In
fact, Hispanics have a higher prevalence of steatohepatitis,
NAFLD and cirrhosis, whereas African-Americans are less
prone to develop liver failure [10–12].
Besides viral, environmental, behavioral, and metabolic
features, genetic factors have also been implicated in the
different susceptibility to develop HCC [13]. In the last
few years, several studies have established the contribu-
tion of single nucleotide polymorphisms (SNPs) in dif-
ferent genes -such as the patatin-like phospholipase-3
(PNPLA3), vitamin D receptor (VDR), transmembrane 6
superfamily member 2 (TM6SF2), beta-parvin (PARVB)
and sorting and assembly machinery component 50
(SAMM50) genes- as causal variants for chronic liver
diseases and their progression towards HCC [14–17].
This study will focus only on the PNPLA3 and VDR
polymorphisms.
A genome-wide association study in a population
comprising Hispanic, African-American and Caucasian
subjects revealed that the SNP rs738409C > G, which
encodes an isoleucine-to-methionine substitution at
position 148 (I148M) in the PNPLA3 gene, is the stron-
gest determinant of hepatic steatosis [18]. Many other
studies in Asian, European and Latin American popula-
tions have since confirmed this association and shown
the implication of this genetic variant in chronic liver
disorders ranging from NAFLD and NASH to cirrhosis
and HCC [19–22].
Moreover, the progression of chronic liver diseases is re-
lated to the presence of genetic polymorphisms in the VDR
gene. In fact, decreased vitamin D levels have increasingly
been recognized in various forms of chronic liver disease
and associated with advanced fibrosis [23, 24]. Patients
with NAFLD were found to present with reduced
vitamin D levels, which were closely related to the histo-
logical severity of hepatic steatosis, necroinflammation
and fibrosis [25, 26].
Several polymorphic sites -such as the bAt (CCA) haplo-
type consisting of the combination of SNPs rs1544410C
(formerly BsmI), rs7975232C (ApaI) and rs731236A (TaqI)-
have been described in the VDR gene [27]. These combined
variants showed a significant association with the fibrosis
progression rate and the occurrence of cirrhosis and HCC
in Caucasian and Asian patients diagnosed with alcohol-
induced liver injury as well as in those chronically infected
with HCV [28–30].
The prevalence of these polymorphisms differs among
ethnic groups [18, 27]. However, there is a paucity of in-
formation about South American populations, whose
genetic background is highly admixed as a result of gen-
erations of intermixing between various groups, includ-
ing Native Americans, Spanish conquistadores, Africans
and a large European immigrant population that arrived
between 1870 and 1950. In the Argentinean population,
for example, further sources of admixture have been in-
troduced by local migration from the rural areas to the
cities between 1930 and 1980, as well as by immigration
from other South American countries [31, 32]. Hence,
the aim of this study was to determine the prevalence of
these genetic polymorphisms and their association with the
genetic ancestry of South American populations, which
may provide useful knowledge for establishing public health
policies aimed at high risk ethnic populations.
Results
The SNPs in PNPLA3 and VDR genes, associated to the
development of chronic liver disease and progression to-
wards liver cancer, have been characterized in 258
healthy unrelated male volunteers. The allele and geno-
type frequencies of these SNPs are presented in Table 1.
No significant differences in age were observed among
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the individuals carrying the different alleles. The distri-
bution of homozygous and heterozygous carriers was
consistent with the expectations of the Hardy-Weinberg
equilibrium (chi-square goodness-of-fit test: p > 0.05 for
all SNPs in all groups).
The molecular evaluation of maternal ancestry reveals
that 74.4 % of the 258 individuals exhibited Native
American lineages (haplogroups A2, B2, C and D1; Fig. 1a);
whereas, as regards paternal ancestry, only 23.6 % of the
samples showed the Native American Q1a3a haplogroup
(Fig. 1b). Moreover, the combined analysis of mitochondrial
DNA (mtDNA) and Y-chromosome single-nucleotide
polymorphisms (Y-SNPs) in each of the 258 recruited indi-
viduals revealed that more than half of them (57.8 %) exhib-
ited maternal Native American haplogroups and paternal
Non-native American ancestry (admixed samples); whereas
17.8 % and 24.4 % of the studied samples showed Native
American and Non-native American ancestry, respectively.
The four studied SNPs were unevenly distributed
among individuals with Non-native American ancestry
compared with those with Native American ancestry
(maternal or paternal lineages). In fact, the frequencies
of bAt (CCA) haplotype (VDR gene) and the GG genotype
of rs738409 polymorphism (PNPLA3 gene) were signifi-
cantly higher among samples with Native American mater-
nal ancestry (63.4 % and 65.4 %, respectively) compared
with those with Non-native American maternal hap-
logroups (32.2 % and 38.4 %, respectively) (p = 0.0005 and
p = 0.0008, respectively; Fig. 2). In addition, these frequen-
cies were unevenly distributed among individuals with
Native American paternal ancestry compared with those
with Non-native American paternal ancestry, being signifi-
cantly higher in those with Native American haplogroups
(54.9 % and 53.1 %, respectively) compared with those with
Non-native American haplogroups (39.8 % and 30.9 %,
respectively) (p = 0.0424 and p = 0.0388, respectively; Fig. 3).
Similar results were observed when examining the relation-
ship between polymorphisms in VDR gene and ancestry
(Additional files 1 and 2).
When the prevalence of the SNP rs738409 (PNPLA3)
was determined according to the combined ancestry of
the samples (maternal and paternal lineages), the un-
favorable genotype GG was significantly higher among
samples with Native American lineages (63.7 %), inter-
mediate among admixed samples (45.1 %, p = 0.03) and
the lowest for samples with Non-native American ances-
try (30.1 %, p = 0.001; Fig. 4).
Similar results were found when the three polymor-
phisms in VDR gene were examined (Additional file 3).
As a consequence, the frequency of the bAt (CCA)
haplotype -which is a result of the combination of the three
SNPs- was significantly higher among samples with mater-
nal and paternal Native American haplogroups (64.6 %),
intermediate among admixed samples (44.9 %, p = 0.03)
and the lowest for samples with Non-native American an-
cestry (29.6 %, p = 0.0008; Fig. 4).
Discussion
Chronic liver disease is an important cause of morbidity
and mortality around the world. The ethnic disparities
Table 1 Allele and genotype frequencies of SNPs rs738409
(PNPLA3), rs1544410, rs7975232, rs731236 and bAt (CCA)
haplotype (VDR)
Allele frequency Genotype frequency (%)
PNPLA3
rs738409 G: 0.74 GG: 55.4
C: 0.26 GC/CC: 44.6
VDR
rs1544410 (BsmI) C: 0.78 CC: 58.9
T: 0.22 CT/TT: 41.1
rs7975232 (ApaI) C: 0.70 CC: 50.4
A: 0.30 CA/AA: 49.6
rs731236 (TaqI) A: 0.75 AA: 55.8
G: 0.25 AG/GG: 44.2
Haplotype bAt (CCA): 32.5
Others haplotypes: 67.5
Fig. 1 Genetic ancestry of the study population. Prevalence of (a)
mitochondrial DNA (mtDNA) haplogroups and (b) Y-chromosome
single-nucleotide polymorphisms (Y-SNPs) among the studied
population
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reported in its burden, prevalence and clinical presenta-
tion are likely attributed to the interaction between en-
vironmental, behavioral, and genetic factors [1, 9]. To
the best of our knowledge, this study is the first to
analyze ethnicity and polymorphisms associated with
susceptibility to chronic liver disease and progression to-
wards HCC in South American populations.
The results presented herein reveal that the distribu-
tion of polymorphisms related to the development of
chronic liver disease and progression towards liver can-
cer exhibits statistical significant differences according to
ethnicity. In fact, the prevalence of host genetic factors
associated with risk of liver steatosis, fibrosis and cirrho-
sis is significantly lower in individuals with Non-native
American ancestry.
In addition to ethnicity, other risk factors have been
associated with the development of chronic liver disease,
such as older age, male gender, alcohol abuse and HBV
and/or HCV infection [1]. To ensure a representative
sample of the general population in the region, 258 unre-
lated male volunteers were enrolled by two blood banks in
Buenos Aires city. The exclusion of HBV and/or HCV in-
fected subjects did not affect sample’s representativeness as
prevalence of HBV and HCV infection in Argentina is
lower than 1 % [33].
Moreover, the proportion of each ancestry pattern in
the collected sample was consistent with previously re-
ported frequencies in the general population [32], and
therefore, no ethnic group was over or underrepresented
in the sample. In this area of Argentina, the more preva-
lent ancestry components for maternal and paternal line-
ages are the European and the Native American, followed
-to a lesser extent- by African haplogroups [32]. Therefore,
these data suggest that the samples with Non-native
American maternal and/or paternal haplogroups ana-
lyzed in this study would predominantly exhibit the
Fig. 2 Influence of maternal ethnic components on the genotype distribution. Prevalence of SNP rs738409 (PNPLA3 gene) and bAt (CCA)
haplotype (VDR gene) among samples of Native American and Non-native American maternal ancestry (*p = 0.0008, **p = 0.0005)
Fig. 3 Influence of paternal ethnic components on the genotype distribution. Prevalence of SNP rs738409 (PNPLA3 gene) and bAt (CCA)
haplotype (VDR gene) among samples of Native American and Non-native American paternal ancestry (*p = 0.0388, **p = 0.0424)
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European component. In addition, the process of ad-
mixture was -as in the rest of South America- sex-
biased, generally involving a Native American maternal
lineage and a Non-native American paternal lineage
[32]. This finding is consistent with fact that the
admixed group included in this study was character-
ized by Native American maternal ancestry and Non-
native American paternal haplogroups.
In general, men are 2-fold more likely to die from
chronic liver disease and cirrhosis than are women. Liver
transplant occurs less commonly in women than in men,
with variable disease outcomes based on etiology [34]. A
prospective study which analyzed epidemiological as-
pects of HCC in South America revealed that the situ-
ation in this region is no different from that in the rest
of the world [35]. In this study, only male subjects were
enrolled to assess both maternal and paternal lineages
and determine the frequency of admixture in the studied
population. In spite of this, the genotype prevalence of
the studied SNPs must be considered as representative
of the general population as it could not be modified by
the lack of women in the recruited sample. However, it
must be acknowledged that the interpretation of the re-
sults presented in this study may be affected by the pos-
sibility of sex difference in the genetic association of
these polymorphisms and disease susceptibility. In fact, a
negative correlation between male sex and the effect of
rs738409 on liver fat content has been reported in
NAFLD patients [36].
In this report, the prevalence of the genetic polymor-
phisms associated with risk of chronic liver disease in
Non-native and Native American samples is in
agreement with previously described frequencies in
European and South American populations [18, 20, 37].
Regarding the GG genotype of SNP rs738409 in
PNPLA3 gene, its frequency was significantly higher in
individuals with Native American ancestry when com-
pared with those exhibiting Non-native American hap-
logroups. In consistency with our results, a high prevalence
of the unfavorable genotype was reported in Hispanics and
in Argentinean patients with NALFD [18, 20]; but unfortu-
nately, the ancestry components of these previously studied
populations remain unknown.
Furthermore, the analysis of VDR polymorphisms
carried out in our study revealed intermediate frequen-
cies between those reported for European and Asian
samples, but similar to those previously published for
Hispanics [37]. This result could be related to the high
admixture levels observed in these populations, which
could be explained by the combined ancestry of mesti-
zos and the fact that Native American populations are
descendants of nomadic Asian communities [37].
In different populations, haplotype structure analysis
of VDR gene has shown high genetic heterogeneity in-
volving different haplotype blocks [37, 38]. In fact,
studies carried out in admixed populations has re-
vealed the importance of genetic heterogeneity since
linkage disequilibrium increases or breaks down differ-
ently in different populations [39, 40]. Considering the
recent admixture of Latin American people, the vari-
ation in the patterns of linkage disequilibrium is not
surprising in view of demographic events and genetic
factors such as drift and recombination during the
process of admixture.
Fig. 4 Influence of maternal and paternal ethnic components on the genotype distribution. Prevalence of SNP rs738409 (PNPLA3 gene) and
bAt (CCA) haplotype (VDR gene) among samples of maternal and paternal Native American ancestry, Native American maternal ancestry and
Non-native American paternal ancestry (admixed samples) and Non-native American maternal and paternal ancestry. *p = 0.03 when comparing
samples with maternal and paternal Native American ancestry with the admixed group; **p = 0.001 and ***p = 0.0008 when comparing samples
with maternal and paternal Native American ancestry with those exhibiting Non-native American maternal and paternal ancestry
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From the genetic perspective, Hispanics or Latinos
generally represent an intricate mixture of European,
Native American, and African lineages, with the propor-
tion of each ancestry component typically depending on
country or area of origin [41]. Recent studies that have
examined the relationships between self-identified ethni-
city, self-estimated admixture proportions and genetic
marker estimated admixture proportions revealed that
Hispanics underestimate their degree of Native American
admixture, confirming that ethnic self-identification is
likely to be complex due to the heterogeneity in individual
admixture proportions and social environments within
this group [32, 42]. Due to its complex diversity, data
obtained from relatively well-defined ethnic groups cannot
be extrapolated to the majority of the South American
population.
Interethnic admixture is either common or rapidly in-
creasing in many -if not most- populations as a result of
human migrations. Therefore, in agreement with our re-
sults, molecular evaluation of ancestry is strongly recom-
mended in studies including this type of multi-ethnic
populations [43]. From this point of view, the South
American population, with Native American, European
and African ancestral roots, and five centuries of vast in-
terethnic admixing, offers a unique model for examining
the impact of admixture on the conceptual development
and clinical implementation of the results obtained from
genomics medicine studies.
The results presented in this study intended to shed
some light on the influence of ethnicity on the distribu-
tion of genetic polymorphisms associated with chronic
liver disease in multi-ethnic and admixed populations.
However, due to the multifactorial aspect of chronic
liver diseases, the high prevalence of PNPLA3 and VDR
genetic factors in Native Americans cannot be consid-
ered as the sole reason for the higher susceptibility of
this ethnic group. Therefore, for the proper interpret-
ation of the results presented herein, it must be taken
into consideration that other genetic (e.g., SAMM50,
PARVB, TM6SF2), environmental and behavioral factors
may -as a whole- contribute to the higher risk of chronic
liver disease in Native Americans [1–6, 16, 17]. In fact,
the Hispanic population has high rates of obesity, dia-
betes and metabolic syndrome [44] which suggest that
other nutritional and genetic factors exert a role in the
increased risk for chronic liver disease in this popula-
tion, as well. Unfortunately, the prevalence of chronic
liver disease in subjects with Native American ethnic
components in the studied area remains unknown to
clarify this hypothesis.
In future decades, the prevalence of risk factors for
chronic liver diseases, such as obesity, alcohol abuse and
HCV chronic infection, is expected to rise [1, 2]. Hence,
the identification of effective genetic markers for chronic
liver disorders would be priceless as it would allow us to
stratify populations according to susceptibility [45]. As a
consequence, in areas exhibiting a highly admixed genetic
background with a significant contribution of Native
American ancestry components -and, therefore, less favor-
able genetic variants-, the results presented in this study
are of substantial relevance for the regional public health.
Conclusion
In conclusion, this study shows -for the first time- that
more than 60 % of individuals with Native American an-
cestry are carriers of high risk genetic polymorphisms
related to chronic liver disease and progression towards
liver cancer. These data not only support the molecular
evaluation of ancestry in multi-ethnic population studies,
but also suggest that the characterization of these vari-
ants among the healthy South American population may
be useful for establishing public health policies aimed at




During the period 2012–2013, a total of 258 unrelated male
volunteers (mean age ± standard deviation: 35.2 years ±
11.5) were recruited by the DNA and blood bank at the
Italian Hospital of Buenos Aires and the blood bank at the
“Sardá” Maternity Hospital in Buenos Aires, Argentina.
Both blood banks are located in different points of Buenos
Aires city and provide attention to all strata of the gen-
eral population (both Argentinean residents and South
American immigrants), reinforcing sample’s representa-
tiveness of the population of this region.
Male gender was considered as an inclusion criteria
for participation in the study in order to determine both
maternal (mitochondrial) and paternal (Y-chromosome)
ancestry in all collected samples. Moreover, all enrolled
subjects exhibited negative serology results for HBV and
HCV infection (AxSYM, Abbott, Chicago, IL, USA) to
avoid the dominant role that those viruses play on the
development of chronic liver disease.
Ethics, consent and permissions
This study has been performed in accordance with the
Declaration of Helsinki. Informed consent was obtained
from each subject according to the experimental research
protocol, approved by the Ethics Committee on Research
from the Italian Hospital of Buenos Aires (CEPI N° 1918).
Isolation of genomic DNA and genotype of PNPLA3 and
VDR
Genomic DNA was extracted from 1 ml of EDTA blood
by using FlexiGene® DNA Kit (QIAGEN, GmbH, Hilden,
Germany) following the manufacturer’s protocol.
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Primers for SNPs rs738409 (PNPLA3) were designed
by using Primer3 software [46]. A 668-bp fragment of
PNPLA3 gene was amplified by the polymerase chain
reaction (PCR) technique using primers 5′-CGA TCT
AGC CCC TTT CAG TC-3′ (forward) and 5′-GCA
GAT TAA GTG AAC CAG CC-3′ (reverse). PCR reac-
tion was carried out for 30 cycles consisting of de-
naturation for 30 s at 94 °C, annealing for 30 s at 62 °C
and extension for 1 min at 72 °C. With regard to SNPs
for VDR gene, the sets of primers used for amplifica-
tion and their PCR cycling conditions were obtained
from previously published studies [47, 48].
The PCR amplified fragments were bi-directionally
sequenced using Big-Dye Termination chemistry system
(Applied Biosystems, Life Technologies Corp., Foster City,
CA, USA). In order to discriminate between homozygotes
and heterozygotes, the sequencing chromatogram was ex-
amined by using BioEdit Sequence Alignment Editor
version 7.1.3.0.
Molecular evaluation of ancestry
Haplogroups in mtDNA (haplogroups A2, B2, C and D1)
and Y-SNPs (haplogroups E1b1b, G2a, I, J2, R1b1b2,
Q1a3a) were assessed by Real-Time PCR followed by High
Resolution Melting as previously described [49].
Statistical analyses
Statistical analyses were carried out using Fisher’s exact
test (group by group comparisons) and a value p < 0.05
was considered as statistically significant. Furthermore,
Holm-Bonferroni correction was used to address the
problem of multiple hypothesis testing.
The correlation between the observed number of homo-
zygous and heterozygous individuals and the numbers
statistically expected from the Hardy-Weinberg equilib-
rium was assessed by the Chi-square goodness-of-fit test.
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Additional file 1: Prevalence of SNPs rs1544410 (BsmI), rs7975232
(ApaI) and rs731236 (TaqI) of VDR gene among samples with Native
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ancestry. *p = 0.0008, **p = 0.0172, ***p = 0.0033. (JPEG 80 kb)
Additional file 2: Prevalence of SNPs rs1544410 (BsmI), rs7975232
(ApaI) and rs731236 (TaqI) of VDR gene among samples with Native
American paternal ancestry and Non-native American paternal
ancestry. *p = 0.0304, **p = 0.0588, ***p = 0.004. (JPEG 87 kb)
Additional file 3: Prevalence of SNPs rs1544410 (BsmI), rs7975232
(ApaI) and rs731236 (TaqI) of the VDR gene among samples of
maternal and paternal Native American ancestry, Native American
maternal ancestry and Non-native American paternal ancestry
(admixed samples) and Non-native American maternal and paternal
ancestry. *p = 0.009, **p = 0.0261 and ***p = 0.0396 when comparing
samples with maternal and paternal Native American ancestry with the
admixed group; †p = 0.0005 and ‡p = 0.001 when comparing samples
with maternal and paternal Native American ancestry with those
exhibiting Non-native American maternal and paternal ancestry.
(JPEG 86 kb)
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